Stock Quote
Illumina, Inc. (ILMN.O) (Nasdaq)
$26.50
23 Nov 2009
-1.16%
$26.50
--
7,018,418
$26.97
$25.59
$44.07
$19.49
0.54
3,514,774
ILMN.O
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Rastetter, William | Chairman of the Board | -- |
| Flatley, Jay | President, Chief Executive Officer, Director | 5,115,080 |
| Henry, Christian | Chief Financial Officer, Senior Vice President - Corporate Development | 2,054,050 |
Profile
Illumina, Inc. is a developer, manufacturer and marketer of integrated systems for the large-scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that serve the sequencing, genotyping and gene expression markets. It also,... Full Description
Company Address
Illumina, Inc.
9885 Towne Centre Drive
San Diego CA 92121
P: +1858.2024500
9885 Towne Centre Drive
San Diego CA 92121
P: +1858.2024500
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Affymetrix, Inc. | $4.77 | -0.07 |
| Agilent Technologies Inc. | $29.28 | +0.37 |
| Beckman Coulter, Inc. | $65.28 | +0.70 |
| ILMN.O | Industry | |
|---|---|---|
| P/E(TTM) | 42.15 | 7.62 |
| P/S(TTM) | 5.13 | 0.46 |
| ROI(TTM) | 8.96 | 0.98 |
| ROE(TTM) | 9.65 | 1.52 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.25 |
| EPS Est. (Current Year) | 0.77 |
| Total Revenue | $158.36M |
| Net Income | $17.08M |
| EPS | $0.12 |
